Hyperfine (HYPR)
(Delayed Data from NSDQ)
$1.16 USD
+0.01 (0.87%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $1.16 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Hyperfine, Inc. (HYPR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$1.27 | $1.60 | $0.90 | 10.43% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Hyperfine, Inc. comes to $1.27. The forecasts range from a low of $0.90 to a high of $1.60. The average price target represents an increase of 10.43% from the last closing price of $1.15.
Analyst Price Targets (3 )
Broker Rating
Hyperfine, Inc. currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 2.33 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, one is Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/15/2024 | B. Riley Securities | Yuan Zhi | Strong Buy | Strong Buy |
3/22/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Hold | Hold |
3/15/2024 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.33 |
# of Recs in ABR | 3 |
Average Target Price | $1.27 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 101 of 253 |
Current Quarter EPS Est: | -0.14 |